Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting M(pro) and Ameliorates Pulmonary Inflammation

The coronavirus disease 2019 (COVID-19) has spread widely around the world and has seriously affected the human health of tens of millions of people. In view of lacking anti-virus drugs target to SARS-CoV-2, there is an urgent need to develop effective new drugs. In this study, we reported our disco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Xiao, Ting, Cui, Mengqi, Zheng, Caijuan, Wang, Ming, Sun, Ronghao, Gao, Dandi, Bao, Jiali, Ren, Shanfa, Yang, Bo, Lin, Jianping, Li, Xiaoping, Li, Dongmei, Yang, Cheng, Zhou, Honggang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248548/
https://ncbi.nlm.nih.gov/pubmed/34220507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.669642
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados